Patents Examined by Mina Haghighatian
  • Patent number: 11976014
    Abstract: The invention relates to the technical field of agricultural planting, in particular to a controlled-release bacterial fertilizer for peanuts and a preparation method of the special controlled-release bacterial fertilizer. The special controlled-release bacterial fertilizer is composed of an inner layer and an outer layer; after the outer layer is released completely, the inner-layer network structure gradually absorbs water and preserves moisture, and has good slow release and controlled release properties, thereby achieving the gradual release of the inner layer, high fertilizer utilization rate, exerting the efficacy of the microbial agent and facilitating the large-area promotion.
    Type: Grant
    Filed: July 20, 2020
    Date of Patent: May 7, 2024
    Assignee: Biotechnology Research Center, Shandong Academy of Agricultural Sciences
    Inventors: Jialei Zhang, Xinguo Li, Shubo Wan, Feng Guo, Jianguo Wang, Zheng Zhang, Gao Chen, Chaohui Tang, Sha Yang, Zhenying Peng, Jingjing Meng
  • Patent number: 11963529
    Abstract: Methods and systems for enhancing production of adenosine triphosphate (ATP) in living organisms are provided. An example method includes generating structurally altered gas molecules from water. The structurally altered gas molecules have a higher probability of attraction of electrons into areas adjunct to the structurally altered gas molecules than molecules of the water. The method further includes infusing the structurally altered gas molecules into a living organism. Upon being infused, the structurally altered gas molecules cause an increase of production of the ATP in the living organism.
    Type: Grant
    Filed: October 4, 2023
    Date of Patent: April 23, 2024
    Assignees: H2Plus LLC, H2Plus Operations, LLC
    Inventors: Gene Dedick, Jared Roberts
  • Patent number: 11957815
    Abstract: An artificial tissue construct for nerve repair and regeneration includes a biocompatible and biodegradable nerve guidance matrix comprising a plurality of biopolymers that include chitosan, gelatin, collagen and hyaluronic acid. A cross-linker includes glutaraldehyde. The nerve guidance matrix is formed as a three-dimensional scaffold polyelectrolyte complex (PEC). A subconfluent and grown monolayer of at least one of human mesenchymal stem cells, mesenchymal stem cells, differentiated Schwann cells and neuronal cells is on the biocompatible and biodegradable nerve guidance matrix for direct implantation or delivery. A method of making the artificial tissue construct is disclosed.
    Type: Grant
    Filed: November 12, 2020
    Date of Patent: April 16, 2024
    Assignee: DATT LIFE SCIENCES PRIVATE LIMITED
    Inventors: Rajan Datt, Siddharth Pandey, Poonam Meena, Mukesh Kumar, Nitin Khatri, Rakesh Kumar Nagar
  • Patent number: 11959065
    Abstract: Provided are bioactive compositions and metabolites derived from Bacillus and particularly Bacillus megaterium cultures responsible for controlling pests as well as their methods of use for controlling pests. Further provided are pesticidal Bacillus megaterium strains.
    Type: Grant
    Filed: June 9, 2022
    Date of Patent: April 16, 2024
    Assignee: PRO FARM GROUP, INC.
    Inventors: Ratnakar Asolkar, Ana Lucia Cordova-Kreylos, Margarita Rodriguez, Carly Todd, Debora Wilk, Pamela G. Marrone
  • Patent number: 11951198
    Abstract: A method for strengthening and repairing keratin fibers including providing a caustic as well as an acidic crosslinking composition, wherein the caustic crosslinking composition comprises an at least bi-functional Brönsted-base and the acidic crosslinking composition comprises an at least bi-functional organic acid, and a cosmetically acceptable carrier; applying the caustic as well as the acidic crosslinking composition to keratin fibers; and optionally mixing the caustic crosslinking composition into a commercially available hair coloring or hair bleaching composition.
    Type: Grant
    Filed: February 11, 2020
    Date of Patent: April 9, 2024
    Assignee: LIW PATENT COMPANY LIMITED BY GUARANTEE
    Inventor: Sabine Wagner
  • Patent number: 11944655
    Abstract: The invention is directed to a microcapsule and the method to obtain it. The microcapsule comprises a core in the form of a lipid sphere coated by a protein film, wherein the lipid sphere comprises sporulated microorganisms and at least one lipid wall material, and the protein film is a mix of carbohydrate, protein material and water. The method to obtain this microcapsule includes the stages of mixing sphere components, mixing protein film components, homogenizing the protein film and the subsequent coating of the lipid sphere by means of fluidization with the protein film.
    Type: Grant
    Filed: September 30, 2020
    Date of Patent: April 2, 2024
    Assignee: Alpina Productos Alimenticios, S.A.
    Inventors: Bernadette Francisca Klotz Ceberio, Maria Ximena Quintanilla Carvajal
  • Patent number: 11944640
    Abstract: The invention relates to pharmaceutical compositions comprising a zinc2+ salt and a ?-polyglutamic acid carrier, and, optionally, an NF-kB inhibitor as a tumor-sensitizing agent, and methods for using such compositions to treat tumors in patients. Methods include administering a liquid dosage form or a solid dosage form of a therapeutically effective amount of a Zn(II) salt and a ?-polyglutamic acid carrier to a patient in need thereof. Methods of treating a broad spectrum of human tumors, including tumors with a drug-resistant phenotype, using the disclosed compositions are provided. Tumors that respond to the pharmaceutical compositions disclosed herein include neuroendocrine (neuroblastoma), gastric, uterine, and lung tumors.
    Type: Grant
    Filed: October 31, 2017
    Date of Patent: April 2, 2024
    Assignee: XYLONIX PTE. LTD.
    Inventor: Jinhyuk Fred Chung
  • Patent number: 11937602
    Abstract: Antimicrobial compositions including at least one acid and at least one anionic surfactant are provided. In particular, food contact antimicrobial compositions including at least one acid and at least one anionic surfactant provide efficacious virucidal activity, including against Norovirus, having acceptable use solution pH that do not require use of personal protective equipment (PPE), are surface compatible and do not leave residues on treated surfaces. Methods of cleaning a surface with the compositions are also provided and may beneficially eliminate the need to rinse the antimicrobial compositions after use.
    Type: Grant
    Filed: September 26, 2018
    Date of Patent: March 26, 2024
    Assignee: ECOLAB USA INC.
    Inventors: Wendy Lo, Derrick Anderson, Erik Olson, Catherine Hanson, Junzhong Li, David D. McSherry, Stacy Fawbush, Kaitlin Lake, Gerard Hinrichs, Joshua Luedtke, Richard Staub
  • Patent number: 11925607
    Abstract: An inhalable pharmaceutical composition comprising ketamine or its pharmaceutically acceptable salt for use in a method of treatment of depression by administration via pulmonary route, treatment comprising cycle of multiple sequences of administration by inhalation, said cycle lasting from 10 days to 30 days, wherein each of multiple sequences of administration is performed in a one single day, with 2 to 4 days intervals between sequences, and each of said sequences consists of multiple single dose inhalations separated by a break period lasting at least 5 minutes. The composition is especially useful for the treatment of treatment-resistant depression.
    Type: Grant
    Filed: September 24, 2019
    Date of Patent: March 12, 2024
    Assignee: CELON PHARMA S.A.
    Inventors: Maciej Wieczorek, Sylwia Janowska
  • Patent number: 11920162
    Abstract: Ex-vivo culture systems are provided. Accordingly there is provided a culture system comprising a culture medium and a precision-cut tissue slice placed on a tissue culture insert, wherein the precision-cut tissue slice is maintained in a highly oxygenated atmosphere containing at least 50% oxygen and wherein said culture is rotationally agitated facilitating intermittent submersion of the tissue slice in the culture medium. Also provided are methods of culturing a tissue and methods of using the culture system for selecting a drug for the treatment of a disease.
    Type: Grant
    Filed: April 3, 2018
    Date of Patent: March 5, 2024
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Ravid Straussman, Nancy Gavert
  • Patent number: 11910793
    Abstract: Multifunctional agricultural adjuvant compositions (“MAACs”) include at least one liquid component and one or more solid agricultural particles dispersed in the liquid component. The liquid component may include at least one methylated seed oil. Examples of the solid agricultural particles include ammonium sulfate, other water conditioners, amino acids, or polymers. The MAAC exhibits one or more desired functions depending on the quantity and composition of the liquid component, the quantity and composition of the solid agricultural particles, and, optionally, adding one or more surfactants and/or one or more additional components (e.g., rheology modifiers) to the MAAC. The desired functions of the MAAC may include at least one of a water conditioner, a surfactant, a high surfactant oil concentrate, a crop oil concentrate, or a drift reduction and a deposition adjuvant.
    Type: Grant
    Filed: January 23, 2020
    Date of Patent: February 27, 2024
    Assignee: WinField Solutions, LLC
    Inventors: Christine M. Colby, Elizabeth Alonzi, Danny M. Brown
  • Patent number: 11905304
    Abstract: Agricultural products, such as pesticides, plant growth regulators, fungicides, herbicides, and insecticides, may be formulated to include one or more surfactants, from one or more surfactant classes, such as siloxane derivatives of amino acids that have surface-active properties.
    Type: Grant
    Filed: December 10, 2020
    Date of Patent: February 20, 2024
    Assignee: AdvanSix Resins & Chemicals LLC
    Inventor: Edward Asirvatham
  • Patent number: 11896571
    Abstract: The invention provides methods for increasing oral osteogenesis using LXA4 and its analogs. Methods are also provided for treating or preventing oral disorders that would benefit from increased oral osteogenesis using LXA4 and its analogs.
    Type: Grant
    Filed: October 7, 2019
    Date of Patent: February 13, 2024
    Assignee: Forsyth Dental Infirmary for Children
    Inventors: Thomas E. Van Dyke, Hatice Hasturk, Alpdogan Kantarci
  • Patent number: 11890381
    Abstract: A present invention relates to a natural lubricant composition, a tablet comprising a natural lubricant composition and a preparation method thereof. The Natural Lubricant composition for a tablet comprises an active lubricant ingredient selected from a corn flour, a corn starch, and an arrowroot flour. The Natural Lubricant composition for a tablet also comprises a natural oil.
    Type: Grant
    Filed: September 8, 2021
    Date of Patent: February 6, 2024
    Assignee: NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD.
    Inventor: Ravleen Singh Khurana
  • Patent number: 11889831
    Abstract: An aqueous slurry composition containing microcapsules dispersed in an aqueous medium. The microcapsules contain an ionic acrylate copolymer shell encapsulating an oily medium. Upon drying, the microcapsules release the oily medium. The slurry is useful in delivering a variety of water-insoluble substances via an aqueous medium including cosmetic or agricultural agents.
    Type: Grant
    Filed: October 17, 2019
    Date of Patent: February 6, 2024
    Assignees: ENCAPSYS, LLC, IPS STRUCTURAL ADHESIVES, INC., IPS CORPORATION, WATERTITE PRODUCTS, INC., WELD-ON ADHESIVES, INC., IPS ADHESIVES LLC
    Inventor: Todd Arlin Schwantes
  • Patent number: 11882834
    Abstract: Compounds of the formula (I), (I) wherein the substituents are as defined in claim 1, useful as pesticides, and especially fungicides.
    Type: Grant
    Filed: November 27, 2018
    Date of Patent: January 30, 2024
    Assignee: SYNGENTA PARTICIPATIONS AG
    Inventors: Martin Pouliot, Stefano Rendine
  • Patent number: 11883528
    Abstract: A pharmaceutical composition for administering directly to the pulmonary tract of a subject includes a salt of triiodothyronine and a pharmaceutically acceptable buffer, adjusted to a pH of 5.5-8.5. The composition can be administered prophylactically or therapeutically to a subject to treat lung inflammation or pulmonary edema.
    Type: Grant
    Filed: August 23, 2022
    Date of Patent: January 30, 2024
    Assignee: Regents of the University of Minnesota
    Inventors: David H. Ingbar, Timothy P. Rich, Robert J. Schumacher, Jianxun Lei, Maneesh Bhargava
  • Patent number: 11884781
    Abstract: The present invention relates to supramolecular biomedical polymers comprising quadruple hydrogen bonding units and to a process for preparing such a supramolecular biomedical polymer and porous biomedical implants thereof. The supramolecular biomedical polymers are particularly suitable for the production of porous biomedical implants that need high strength, elasticity, durability, and slow biodegradation, e.g. medical implants for living tissue regeneration within a mammal, such as the treatment of cardio-vascular diseases, medical prolapses, and hernias.
    Type: Grant
    Filed: May 19, 2020
    Date of Patent: January 30, 2024
    Assignee: SUPRAPOLIX B.V.
    Inventors: Tristan Mes, Anton Willem Bosman, Joris Wilhelmus Peeters, Henricus Marie Janssen
  • Patent number: 11865206
    Abstract: The present invention relates to a ready-to-use solution of carmustine that does not require dissolution or dilution of the carmustine prior to addition to saline and dextrose parenteral solutions. In particular, the invention relates to a stable liquid pharmaceutical composition containing carmustine in the form of ready-to-use solution and method for preparing the same.
    Type: Grant
    Filed: December 28, 2022
    Date of Patent: January 9, 2024
    Assignee: EMCURE PHARMACEUTICALS LTD
    Inventors: Sougata Pramanick, Aasiya Aslam Burhan, Mukund Keshav Gurjar, Hiren Pravinbhai Patel, Deepak Pragjibhai Gondaliya
  • Patent number: 11850294
    Abstract: A microcapsule composition comprising at least one polymer substantially disposed as a semipermeable shell around an aqueous buffered solution and at least one agent, wherein the agent permeates the shell, and wherein the composition is suitable for delivery to a mammal.
    Type: Grant
    Filed: November 23, 2021
    Date of Patent: December 26, 2023
    Assignee: Premier Dental Products Company
    Inventors: Mark A. Latta, Stephen M. Gross, William A McHale